Diabetes, Vol 45, Issue 10 1329-1335, Copyright © 1996 by American Diabetes Association

ARTICLES

Glucosamine-induced inhibition of liver glucokinase impairs the ability of hyperglycemia to suppress endogenous glucose production

N Barzilai, M Hawkins, I Angelov, M Hu and L Rossetti
Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

Although the kinetic characteristics of hepatic glucokinase (GK) suggest its potential role as the hepatic "glucose sensor," its impact on the regulation of in vivo hepatic glucose production (HGP) is still controversial. Since decreased GK activity has been linked to experimental and human diabetes, we examined whether a moderate and transient inhibition of GK activity diminishes the ability of hyperglycemia to suppress HGP. We first determined the concentration of the competitive inhibitor, glucosamine (GlcN), which decreases hepatic GK activity by approximately 60% in vitro. GlcN was then infused into conscious rats to achieve a similar inhibition of the in vivo GK activity (plasma GlcN levels = approximately 2 mmol/l; rats infused with saline served as control, n = 20). To maintain equal plasma insulin and glucagon concentrations throughout the studies, somatostatin and insulin (basal replacement) were infused for 4 h. [3-(3H)]-glucose and [U-(14C)]-lactate were infused to measure HGP, gluconeogenesis, and glucose cycling (GC) during 2 h of euglycemia (glucose approximately 8 mmol/l) followed by 2 h of hyperglycemia (glucose approximately 18 mmol/l). Our results support the notion that hepatic GK activity is indeed decreased by GlcN in vivo. In fact, in response to hyperglycemia the "direct" pathway of hepatic glucose-6-phosphate (G-6-P) formation was approximately 40% lower with GlcN compared with saline infusion (37 +/- 3 vs. 63 +/- 3%; P < 0.001). Furthermore, while hyperglycemia stimulated GC by approximately 2.5-fold during saline infusion (from 3.0 +/- 0.6 to 7.7 +/- 1.4 mg.kg-1.min-1, P < 0.001, euglycemia vs. hyperglycemia), this increase was blunted in the presence of GlcN (4.6 +/- 0.6 mg.kg-1.min-1, P = NS). Finally, in the presence of GlcN, the hepatic concentration of G-6-P was decreased by approximately 40% compared with saline (234 +/- 38 and 390 +/- 24 nmol/g, P < 0.01). During the euglycemic studies, HGP was similar (12.6 +/- 0.6 and 11.3 +/- 0.2 mg .kg-1.min-1 with GlcN or saline infusion, respectively). However, while hyperglycemia per se suppressed HGP by approximately 65%, HGP was inhibited by approximately 38% and it was approximately twofold higher than in the saline-infused rats (7.8 +/- 0.8 and 4.0 +/- 0.3 mg.kg-1.min-1, P < 0.01) in the presence of GlcN-induced inhibition of hepatic GK. This increase in HGP was largely accounted for by the decreased inhibition of hepatic net glycogenolysis by hyperglycemia (3.3 +/- 0.8 and 1.1 +/- 0.3 mg.kg-1.min-1 with GlcN or saline infusion, respectively, P < 0.01). We conclude that intact GK activity is required for the normal suppression of HGP by hyperglycemia and its impairment may contribute to increased HGP in experimental and human diabetes.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J.-S. Shin, T. P. Torres, R. L. Catlin, E. P. Donahue, and M. Shiota A defect in glucose-induced dissociation of glucokinase from the regulatory protein in Zucker diabetic fatty rats in the early stage of diabetes Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1381 - R1390. [Abstract] [Full Text] [PDF]

				S. Fishman, R. H. Muzumdar, G. Atzmon, X. Ma, X. Yang, F. H. Einstein, and N. Barzilai Resistance to leptin action is the major determinant of hepatic triglyceride accumulation in vivo FASEB J, January 1, 2007; 21(1): 53 - 60. [Abstract] [Full Text] [PDF]

				R. Muniyappa, R. J. Karne, G. Hall, S. K. Crandon, J. A. Bronstein, M. R. Ver, G. L. Hortin, and M. J. Quon Oral Glucosamine for 6 Weeks at Standard Doses Does Not Cause or Worsen Insulin Resistance or Endothelial Dysfunction in Lean or Obese Subjects Diabetes, November 1, 2006; 55(11): 3142 - 3150. [Abstract] [Full Text] [PDF]

				Y. Fujimoto, T. P. Torres, E. P. Donahue, and M. Shiota Glucose Toxicity Is Responsible for the Development of Impaired Regulation of Endogenous Glucose Production and Hepatic Glucokinase in Zucker Diabetic Fatty Rats Diabetes, September 1, 2006; 55(9): 2479 - 2490. [Abstract] [Full Text] [PDF]

				L. M. Gronning, R. Tingsabadh, K. Hardy, K. T. Dalen, P. S. Jat, L. Gnudi, and P. R. Shepherd Glucose induces increases in levels of the transcriptional repressor Id2 via the hexosamine pathway Am J Physiol Endocrinol Metab, April 1, 2006; 290(4): E599 - E606. [Abstract] [Full Text] [PDF]

				F. H. Einstein, G. Atzmon, X.-m. Yang, X.-H. Ma, M. Rincon, E. Rudin, R. Muzumdar, and N. Barzilai Differential Responses of Visceral and Subcutaneous Fat Depots to Nutrients Diabetes, March 1, 2005; 54(3): 672 - 678. [Abstract] [Full Text] [PDF]

				C. Bouche, S. Serdy, C. R. Kahn, and A. B. Goldfine The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes Endocr. Rev., October 1, 2004; 25(5): 807 - 830. [Abstract] [Full Text] [PDF]

				P. Vuguin, E. Raab, B. Liu, N. Barzilai, and R. Simmons Hepatic Insulin Resistance Precedes the Development of Diabetes in a Model of Intrauterine Growth Retardation Diabetes, October 1, 2004; 53(10): 2617 - 2622. [Abstract] [Full Text] [PDF]

				Y. Fujimoto, E. P. Donahue, and M. Shiota Defect in glucokinase translocation in Zucker diabetic fatty rats Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E414 - E423. [Abstract] [Full Text] [PDF]

				C. A. Chu, Y. Fujimoto, K. Igawa, J. Grimsby, J. F. Grippo, M. A. Magnuson, A. D. Cherrington, and M. Shiota Rapid translocation of hepatic glucokinase in response to intraduodenal glucose infusion and changes in plasma glucose and insulin in conscious rats Am J Physiol Gastrointest Liver Physiol, April 1, 2004; 286(4): G627 - G634. [Abstract] [Full Text] [PDF]

				M. Hawkins, J. Tonelli, P. Kishore, D. Stein, E. Ragucci, A. Gitig, and K. Reddy Contribution of Elevated Free Fatty Acid Levels to the Lack of Glucose Effectiveness in Type 2 Diabetes Diabetes, November 1, 2003; 52(11): 2748 - 2758. [Abstract] [Full Text] [PDF]

				D. A. Scroggie, A. Albright, and M. D. Harris The Effect of Glucosamine-Chondroitin Supplementation on Glycosylated Hemoglobin Levels in Patients With Type 2 Diabetes Mellitus: A Placebo-Controlled, Double-blinded, Randomized Clinical Trial Arch Intern Med, July 14, 2003; 163(13): 1587 - 1590. [Abstract] [Full Text] [PDF]

				I. Gabriely, X. H. Ma, X. M. Yang, G. Atzmon, M. W. Rajala, A. H. Berg, P. Scherer, L. Rossetti, and N. Barzilai Removal of Visceral Fat Prevents Insulin Resistance and Glucose Intolerance of Aging: An Adipokine-Mediated Process? Diabetes, October 1, 2002; 51(10): 2951 - 2958. [Abstract] [Full Text] [PDF]

				M. Hawkins, I. Gabriely, R. Wozniak, K. Reddy, L. Rossetti, and H. Shamoon Glycemic Control Determines Hepatic and Peripheral Glucose Effectiveness in Type 2 Diabetic Subjects Diabetes, July 1, 2002; 51(7): 2179 - 2189. [Abstract] [Full Text] [PDF]

				M. Hawkins, I. Gabriely, R. Wozniak, C. Vilcu, H. Shamoon, and L. Rossetti Fructose Improves the Ability of Hyperglycemia Per Se to Regulate Glucose Production in Type 2 Diabetes Diabetes, March 1, 2002; 51(3): 606 - 614. [Abstract] [Full Text] [PDF]

				I. Gabriely, X. M. Yang, J. A. Cases, X. H. Ma, L. Rossetti, and N. Barzilai Hyperglycemia modulates angiotensinogen gene expression Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2001; 281(3): R795 - R802. [Abstract] [Full Text] [PDF]

				M. Shiota, C. Postic, Y. Fujimoto, T. L. Jetton, K. Dixon, D. Pan, J. Grimsby, J. F. Grippo, M. A. Magnuson, and A. D. Cherrington Glucokinase Gene Locus Transgenic Mice Are Resistant to the Development of Obesity-Induced Type 2 Diabetes Diabetes, March 1, 2001; 50(3): 622 - 629. [Abstract] [Full Text]

				M. Nawano, A. Oku, K. Ueta, I. Umebayashi, T. Ishirahara, K. Arakawa, A. Saito, M. Anai, M. Kikuchi, and T. Asano Hyperglycemia contributes insulin resistance in hepatic and adipose tissue but not skeletal muscle of ZDF rats Am J Physiol Endocrinol Metab, March 1, 2000; 278(3): E535 - E543. [Abstract] [Full Text] [PDF]

				L. Guignot and G. Mithieux Mechanisms by which insulin, associated or not with glucose, may inhibit hepatic glucose production in the rat Am J Physiol Endocrinol Metab, December 1, 1999; 277(6): E984 - E989. [Abstract] [Full Text] [PDF]

				R. C. Cooksey, L. F. Hebert Jr., J.-H. Zhu, P. Wofford, W. T. Garvey, and D. A. McClain Mechanism of Hexosamine-Induced Insulin Resistance in Transgenic Mice Overexpressing Glutamine:Fructose-6-Phosphate Amidotransferase: Decreased Glucose Transporter GLUT4 Translocation and Reversal by Treatment with Thiazolidinedione Endocrinology, March 1, 1999; 140(3): 1151 - 1157. [Abstract] [Full Text]

				C. Postic, M. Shiota, K. D. Niswender, T. L. Jetton, Y. Chen, J. M. Moates, K. D. Shelton, J. Lindner, A. D. Cherrington, and M. A. Magnuson Dual Roles for Glucokinase in Glucose Homeostasis as Determined by Liver and Pancreatic beta  Cell-specific Gene Knock-outs Using Cre Recombinase J. Biol. Chem., January 1, 1999; 274(1): 305 - 315. [Abstract] [Full Text] [PDF]

				D. Massillon, W. Chen, N. Barzilai, D. Prus-Wertheimer, M. Hawkins, R. Liu, R. Taub, and L. Rossetti Carbon Flux via the Pentose Phosphate Pathway Regulates the Hepatic Expression of the Glucose-6-phosphatase and Phosphoenolpyruvate Carboxykinase Genes in Conscious Rats J. Biol. Chem., January 2, 1998; 273(1): 228 - 234. [Abstract] [Full Text] [PDF]

				L. Rossetti, W. Chen, M. Hu, M. Hawkins, N. Barzilai, and S. Efrat Abnormal regulation of HGP by hyperglycemia in mice with a disrupted glucokinase allele Am J Physiol Endocrinol Metab, October 1, 1997; 273(4): E743 - E750. [Abstract] [Full Text] [PDF]